Key Takeaways
- • Charta Health, a San Francisco-based AI medical chart review platform focused on billing accuracy, announced a $55 million Series B funding round.
- • The round was led by Insight Partners, with existing investors Madrona, Bain Capital Ventures, and South Park Commons participating alongside QuantumLight.
- • Charta's autonomous AI chart review serves both healthcare providers, to ensure claims are accurately coded and supported, and health plans, for revenue integrity and compliance on Medicare Advantage and ACA Marketplace plans.
Summary
The company describes its platform as an AI medical chart review system built for billing accuracy. It delivers autonomous AI chart review to healthcare providers and insurance companies. For providers, the platform uses AI to ensure claims are accurately coded and adequately supported by clinical documentation, with the stated aim of helping them get paid correctly for care delivered.
For health plans, Charta analyzes clinical documentation at scale to support revenue integrity and compliance, with a focus on Medicare Advantage and ACA Marketplace plans. The company identifies Insight Partners, Bain Capital Ventures, Madrona Venture Group, and other leading investors among its backers.
The source material does not disclose valuation, total funds raised to date, or revenue and customer metrics.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.